Aligo Annual Report News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Aligos Therapeutics Announces First Subjects Dosed in the Phase 2a HERALD Study of ALG-055009 in MASH Subjects

SOUTH SAN FRANCISCO, Calif., April 03, 2024 Aligos Therapeutics, Inc. , a clinical stage biopharmaceutical company focused on developing novel therapeutics to address unmet medical needs in.

United statesJordyn taraziMichael fitzhughLawrence blattAligos therapeutics incExchange commissionInvestor relations corporate communicationsExchange commission onLifesci communicationsChief executive officerSecurities litigation reform actAligo annual reportInvestor relations

Aligos Therapeutics Inc (ALGS) Presents Positive Clinical Data from ALG-055009 and ALG-000184 Phase 1 Studies

Aligos Therapeutics Inc (ALGS) Presents Positive Clinical Data from ALG-055009 and ALG-000184 Phase 1 Studies
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Lawrence blattFung yuenJinlin houMegan fitzgeraldCompanyjordyn taraziviceInvestor relations corporate communicationsSouthern medical universityDivision of gastroenterologyExchange commissionMediamichael fitzhugh lifesci communicationsUniversity of hong kongExchange commission onDepartment of infectious diseasesAligos therapeutics incAligosaligos therapeutics incAligos therapeutics

Aligos Therapeutics Presents Positive Clinical Data at APASL 2024 from ALG-055009 and ALG-000184 Phase 1 Studies

Aligos Therapeutics Presents Positive Clinical Data at APASL 2024 from ALG-055009 and ALG-000184 Phase 1 Studies
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Megan fitzgeraldFung yuenLawrence blattCompanyjordyn taraziviceJinlin houDepartment of infectious diseasesExchange commissionUniversity of hong kongDivision of gastroenterologySouthern medical universityMediamichael fitzhugh lifesci communicationsAligos therapeutics incExchange commission onInvestor relations corporate communicationsAligosaligos therapeutics incAnnual meeting

Aligos Therapeutics Reports Recent Business Progress and Fourth Quarter and Full Year 2023 Financial Results

Aligos Therapeutics Reports Recent Business Progress and Fourth Quarter and Full Year 2023 Financial Results
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Lawrence blattJordyn taraziVeronica eamesNational institute of allergyEuropean congressInvestor relations corporate communicationsCompany annual report on formLifesci communicationsExchange commissionAligos therapeutics incExchange commission onTherapeutics reports recent business progressFourth quarterFull yearAsian pacific associationEuropean association

Aligos Therapeutics to Present Data from Chronic Hepatitis

SOUTH SAN FRANCISCO, Calif., April 11, 2023 (GLOBE NEWSWIRE) Aligos Therapeutics, Inc. (Nasdaq: ALGS), a clinical stage biopharmaceutical company.

Jin hongLawrence blattAlina jucovCorey davisKusum guptaJinlin houYannick debingAmy jobeTongfei wuExchange commissionExchange commission onAligos therapeutics incLifesci communicationsEuropean associationScientific presentationsSecurities litigation reform act